Therapeutic efficacy and safety of Botulinum Toxin A Therapy in Trigeminal Neuralgia : a systematic review and meta-analysis of randomized controlled trials

Conclusion Despite limited data, our results suggest that BTX-A may be an effective and safe treatment option for patients with TN. Further larger and well-designed RCTs are encouraged to translate these findings into better clinical outcome and better quality of life for TN patients.
Source: The Journal of Headache and Pain - Category: Neurology Source Type: research